Patients prescribed statins for CV risk reduction are more than twice as likely to develop type 2 diabetes compared to non-statin users, a study out of Ohio State University has found.
Medical directors of cardiac catheterization and EP labs receive three to four times the amount of money from pharmaceutical companies and device manufacturers as other interventional cardiologists in the same zip code, according to a JAMA Internal Medicine study.
San Francisco will be the first city in the U.S. to ban the sale and distribution of e-cigarettes, NPR reported Tuesday—a significant move considering the nation’s biggest producer of e-cigs, Juul Labs, is based in the city.
Four universities were awarded research grants by the American Heart Association on June 24, each set to receive more than $3.7 million for a range of studies focused on arrhythmias and sudden cardiac arrest.
French drugmaker Sanofi is cutting 466 jobs as part of an R&D “reshuffle” that will also put an end to the company’s new research efforts in cardiology.
A little over a quarter of cardiologists report feeling burned out on the job—something that’s increasingly recognized as a barrier to quality healthcare—according to a recent survey from the American College of Cardiology.
CMS on June 21 issued its finalized national coverage determination for TAVR—one that reportedly offers greater flexibility for hospitals and providers.
Cockrell School of Engineering, The University of Texas at Austin
A team of University of Texas at Austin researchers are looking to replace the decades-old electrocardiography process with a more comprehensive, streamlined way to monitor heart health: e-tattoos.
The Joint Commission and American Heart Association will start accepting applications for two new heart attack programs July 1, including the Acute Heart Attack Ready and Primary Heart Attack Center certifications.
Researchers at Kazan Federal University in Russia are in the process of testing biodegradable plant-based implants that might one day replace artificial prostheses, eliminating the need for repeat surgeries as a patient’s vasculature evolves.
